James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 44,312 shares at $1.68 ($73K) on 2016-04-19, disclosed to the SEC on 2016-11-18.
Open-market sale of $73k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.68 | 33,100 | $56K | 76.0% |
| 2 | $1.57 | 11,212 | $18K | 24.0% |
| Total | $1.65 avg | 44,312 | $73K | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |